Chengdu Shengnuo Biotechnology Co., Ltd was established in 2001, the company is a national high-tech enterprise with 'Sichuan peptide drug engineering technology research center', among which more than 150 people are engaged in the CDMO work of peptide drugs.

A number of API production lines have passed the official GMP certification of China, the United States, South Korea and Mexico successively; injection production lines cover freeze-dried powder injection, schering bottle injection, pre-filled injection and cartridge injection, and many products are on the market; Relying on the most comprehensive peptide drug research platform in China (covering independent research teams and production workshops from small test, pilot test to batch production, as well as independent quality research teams and independent NMPA/FDA double-rigistration work teams), we provides a full chain CMC Research Services for Peptide Drugs.